“The Enabling Formulation service explores non-GMP formulation strategies, including prototype formulations suitable for toxicology studies. These strategies include simple screening approaches, for example, co-solvents and liquid formulation vehicles, inclusion complexes, and the formation of salts or cocrystals. More complex approaches, such as nanosuspensions, lipid-based formulations, and amorphous solid dispersions (ASDs), can also be explored.”
Olana Couzins, Veranova’s Associate Director, Analytical Services, spoke to Drug, Development and Delivery to discuss formulation strategies for improved drug candidate performance in preclinical studies.
